More about

Oregon Health And Science University

News
September 10, 2020
4 min read
Save

New data further support novel treatment for Cushing’s syndrome

New data further support novel treatment for Cushing’s syndrome

The steroidogenesis inhibitor levoketoconazole improved and normalized morning urinary free cortisol concentrations for adults with endogenous Cushing’s disease compared with placebo, according to an industry press release.

News
July 21, 2020
13 min read
Save

Pandemic spurs paradigm shift in artificial intelligence

Pandemic spurs paradigm shift in artificial intelligence

The pandemic has accelerated digitalization in all fields, including health care.

News
June 26, 2020
4 min read
Save

Guidance for pituitary disease management during COVID-19

Guidance for pituitary disease management during COVID-19

The COVID-19 pandemic presents substantial challenges for pituitary disease management, and clinicians should consider local conditions and hospital resources when opting for surgery vs. medical management, according to new guidance.

News
June 19, 2020
10 min read
Save

Telehealth shift during COVID-19 pandemic shows capacity to deliver safe, convenient care

Telehealth shift during COVID-19 pandemic shows capacity to deliver safe, convenient care

As clinicians around the country rapidly transition from in-person to telehealth visits during the COVID-19 pandemic, many changes must be managed at once. Endocrinologists in particular are working to find new ways to support people with diabetes who rely on data-driven care and multiple in-person visits each year, as well as patients with other chronic endocrine conditions that require close follow-up, such as osteoporosis, pituitary tumors or adrenal disease.

News
April 17, 2020
4 min read
Save

Quality of life assessments in oncology trials often don’t — but should — go ‘well beyond treatment’

Quality of life assessments in oncology trials often don’t — but should — go ‘well beyond treatment’

Most oncology clinical trials that assess quality of life do so only during or shortly after the treatment or intervention rather than continuing after disease progression or until death, according to results of a cross-sectional analysis published in JAMA Network Open.

News
April 15, 2020
5 min read
Save

‘Sound evidence base’ needed amid growing acceptance of cannabis for patients with cancer

‘Sound evidence base’ needed amid growing acceptance of cannabis for patients with cancer

Medical cannabis is now legal in 33 states, most of which consider cancer a qualifying condition for its use in symptom palliation.

News
March 25, 2020
14 min read
Save

Palliative care flourishing but ‘significant hurdles’ remain

Palliative care flourishing but ‘significant hurdles’ remain

With one in six cancer survivors reporting high-impact chronic pain that limits their life and work activities, palliative care increasingly has been recognized as an important component of cancer treatment and survivorship.

News
March 23, 2020
3 min read
Save

Industry payments to academic oncologists common, sometimes sizable compared with salaries

Industry payments to academic oncologists common, sometimes sizable compared with salaries

Many academic oncologists at U.S. public medical schools receive considerable industry payments, some of which are sizeable compared with their annual salaries, according to a research letter published in JAMA Internal Medicine.

News
March 23, 2020
5 min read
Save

NTM lung disease: Assessment and determining course of treatment

NTM lung disease: Assessment and determining course of treatment

Nontuberculous mycobacterial (NTM) lung disease is a chronic and debilitating condition, and although considered rare, some studies have estimated that prevalence is increasing about 8% each year in the United States. In 2019, it was estimated that 98,000 to 113,000 patients were diagnosed with the condition, according to unpublished data.

News
February 28, 2020
3 min read
Save

Targeted conditioning improves transplant rate for relapsed, refractory AML

ORLANDO — Targeted conditioning with anti-CD45 iodine apamistamab enabled older, heavily pretreated patients with relapsed or refractory acute myeloid leukemia to undergo hematopoietic stem cell transplantation with successful engraftment, according to preliminary results of the randomized phase 3 SIERRA trial presented at TCT | Transplantation & Cellular Therapy Meetings.

View more